Five Prime Therapeutics Inc
PHARMACEUTICAL FORMULATIONS CONTAINING CD80 EXTRACELLULAR DOMAIN-FC FUSION PROTEINS
Last updated:
Abstract:
The present disclosure provides pharmaceutical compositions comprising CD80 extracellular domain (ECD)-fragment crystallizable (Fc) fusion molecules. The present disclosure also provides methods for treating solid tumors by administering such pharmaceutical compositions.
Status:
Application
Type:
Utility
Filling date:
1 May 2020
Issue date:
21 Jul 2022